Receptors, Interleukin-2

"Receptors, Interleukin-2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Receptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN.

Descriptor ID	D015375
MeSH Number(s)	D12.776.543.750.705.852.420.320
Concept/Terms	Receptors, Interleukin-2 Receptors, Interleukin-2 Receptors, Interleukin 2 TCGF Receptor TCGF Receptors Receptors, TCGF IL-2 Receptor IL 2 Receptor Receptor, IL-2 IL-2 Receptors IL 2 Receptors T-Cell Growth Factor Receptor T Cell Growth Factor Receptor IL2 Receptors Receptors, IL2 Interleukin 2 Receptor Receptor, Interleukin 2 Interleukin-2 Receptors Interleukin 2 Receptors Receptor, TCGF Receptors, IL-2 Receptors, IL 2 Receptors, T-Cell Growth Factor Receptors, T Cell Growth Factor T-Cell Growth Factor Receptors T Cell Growth Factor Receptors IL2 Receptor Receptor, IL2

Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-2".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptors, Immunologic [D12.776.543.750.705]
Receptors, Cytokine [D12.776.543.750.705.852]
Receptors, Interleukin [D12.776.543.750.705.852.420]
Receptors, Interleukin-2 [D12.776.543.750.705.852.420.320]

Below are MeSH descriptors whose meaning is related to "Receptors, Interleukin-2".

Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-2".

Receptors, Interleukin-2
Interleukin Receptor Common gamma Subunit
Interleukin-2 Receptor alpha Subunit
Interleukin-2 Receptor beta Subunit

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, Interleukin-2" by people in this website by year, and whether "Receptors, Interleukin-2" was a major or minor topic of these publications.

Bar chart showing 17 publications over 11 distinct years, with a maximum of 3 publications in 2000 and 2005

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	2	1	3
2001	0	1	1
2002	0	1	1
2003	0	1	1
2004	0	2	2
2005	0	3	3
2006	0	2	2
2009	1	0	1
2014	0	1	1
2018	0	1	1
2021	1	0	1

Below are the most recent publications written about "Receptors, Interleukin-2" by people in Profiles.

Santos AH, Leghrouz MA, Bueno EP, Andreoni KA. Impact of antibody induction on the outcomes of new onset diabetes after kidney transplantation: a registry analysis. Int Urol Nephrol. 2022 Mar; 54(3):637-646.

View in: PubMed
Merrill SA, Naik R, Streiff MB, Shanbhag S, Lanzkron S, Braunstein EM, Moliterno AM, Brodsky RA. A prospective quality improvement initiative in adult hemophagocytic lymphohistiocytosis to improve testing and a framework to facilitate trigger identification and mitigate hemorrhage from retrospective analysis. Medicine (Baltimore). 2018 Aug; 97(31):e11579.

View in: PubMed
Phillips SM, Bhopale MK, Hilliard B, Zekavat SA, Ali MA, Rostami A. Suppression of murine experimental autoimmune encephalomyelitis by interleukin-2 receptor targeted fusion toxin, DAB(389)IL-2. Cell Immunol. 2010; 261(2):144-52.

View in: PubMed
Chichester JA, Feitelson MA, Calkins CE. Transient inhibition of Th1-type cytokine production by CD4 T cells in hepatitis B core antigen immunized mice is mediated by regulatory T cells. Immunology. 2006 Aug; 118(4):438-48.

View in: PubMed
Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol. 2006 Mar; 54(3 Suppl 2):S67-80.

View in: PubMed
Yamazaki S, Patel M, Harper A, Bonito A, Fukuyama H, Pack M, Tarbell KV, Talmor M, Ravetch JV, Inaba K, Steinman RM. Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci U S A. 2006 Feb 21; 103(8):2758-63.

View in: PubMed
Page ST, Plymate SR, Bremner WJ, Matsumoto AM, Hess DL, Lin DW, Amory JK, Nelson PS, Wu JD. Effect of medical castration on CD4+ CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and/or its metabolites. Am J Physiol Endocrinol Metab. 2006 May; 290(5):E856-63.

View in: PubMed
Semmo N, Day CL, Ward SM, Lucas M, Harcourt G, Loughry A, Klenerman P. Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology. 2005 May; 41(5):1019-28.

View in: PubMed
Dionne CJ, Tse KY, Weiss AH, Franco CB, Wiest DL, Anderson MK, Rothenberg EV. Subversion of T lineage commitment by PU.1 in a clonal cell line system. Dev Biol. 2005 Apr 15; 280(2):448-66.

View in: PubMed
Dang NH, Hagemeister FB, Pro B, McLaughlin P, Romaguera JE, Jones D, Samuels B, Samaniego F, Younes A, Wang M, Goy A, Rodriguez MA, Walker PL, Arredondo Y, Tong AT, Fayad L. Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma. J Clin Oncol. 2004 Oct 15; 22(20):4095-102.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement